This site is intended for healthcare professionals only
LoginRegister
PM Modi addresses Indian Association of Physiotherapists conference, explains their vital role in disastersPM Modi addresses Indian Association of Physiotherapists conference, explains their vital role in...
Sale of drugs without licence: DCGI issues show cause notices to Amazon, Flipkart Health plus among 20 online sellersSale of drugs without licence: DCGI issues show cause notices to Amazon, Flipkart Health plus among...
1602 DM, MCh, DNB SS seats up for grabs in MCC NEET SS Counselling 2022, Check out detailed seat matrix, Schedule, eligibility criteria for mop-up round1602 DM, MCh, DNB SS seats up for grabs in MCC NEET SS Counselling 2022, Check out detailed seat...
Adverse drug reactions from normal saline: Punjab imposes 3-year ban on Captab BiotechPunjab: Guru Nanak Dev hospital bars entry of touts of private labs, chemists on campus
PGIMER To Conduct Round 3 Of Counselling Process For INI CET January 2023 SessionPGIMER To Conduct Round 3 Of Counselling Process For INI CET January 2023 Session
1 PG medical Seat for every MBBS graduate in Next 4 Years: Health Minister1 PG medical Seat for every MBBS graduate in Next 4 Years: Health Minister
Haryana FDA seals medical store for selling medicines at rates higher than MRPHaryana FDA seals medical store for selling medicines at rates higher than MRP
AIIMS Rajkot likely to be fully operational by October 2023AIIMS Rajkot likely to be fully operational by October 2023
Natco Pharma announces submission of ANDA with USFDA for generic version of Olaparib TabletsNatco Pharma announces submission of ANDA with USFDA for generic version of Olaparib Tablets
doctor deathAyurvedic doctor shot dead inside clinic by miscreants in Ghaziabad
MUHS Informs on Submission Of Dissertation For PG Ayurveda, Unani, Homeopathy CoursesMUHS Informs on Submission Of Dissertation For PG Ayurveda, Unani, Homeopathy Courses
Biocon Pharma, Carnegie Pharma gain USFDA tentative nod for Rifaximin Tablets to treat irritable bowel syndrome with diarrheaBiocon partner Viatris gets Complete Response Letter from USFDA for Bevacizumab license application
X